StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb Co. (BMY) PT Raised to $67 at Goldman Sachs
February 7, 2025 7:48 AM
Goldman Sachs analyst Chris Shibutani raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $67.00 (from $65.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Bristol-Myers Squibb Co. (BMY) PT Lowered to $68 at Leerink Partners
February 7, 2025 6:21 AM
Bristol-Myers Squibb Co. (BMY) PT Raised to $62 at Wells Fargo
February 7, 2025 6:21 AM
Form 8-K BRISTOL MYERS SQUIBB CO For: Feb 06
February 6, 2025 7:46 AM
Bristol Myers misses expectations for 2025 guidance, shares fall
February 6, 2025 7:33 AM
Bristol Myers forecasts steeper drop in 2025 revenue, shares fall
February 6, 2025 7:07 AM
Bristol-Myers Squibb (BMY) Tops Q4 EPS by 20c; guides below consensus
February 6, 2025 7:00 AM
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024
February 6, 2025 6:59 AM
Bristol-Myers Squibb (BMY) call put ratio 9.2 calls to 1 put with a focus on May 16.50 calls into quarter results
February 5, 2025 11:05 AM
Bristol-Myers Squibb (BMY) call put ratio 1.6 calls to 1 put into quarter results
February 5, 2025 5:12 AM
